Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 2456-2459, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohn, J. S.
Right arrow Articles by Schaefer, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohn, J. S.
Right arrow Articles by Schaefer, E. J.

Clinical Chemistry, Vol 34, 2456-2459, Copyright © 1988 by American Association for Clinical Chemistry

Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states

JS Cohn, JR McNamara and EJ Schaefer
USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111.

Lipoprotein cholesterol concentrations in plasma are routinely estimated by using the Friedewald formula, whereby very-low-density lipoprotein cholesterol (VLDL-C) is estimated to be one-fifth the plasma triglyceride concentration. Ordinarily, this formula is applied only to plasma sampled from patients in the fasted state. To determine whether lipoprotein cholesterol measurements are altered substantially in plasma sampled from nonfasting subjects, we obtained postprandial blood samples from 22 healthy subjects (nine men, 13 women, ages 22-79 years) fed a fat-rich meal (1 g fat per kilogram body wt.). The plasma triglyceride concentration increased postprandially in all subjects (233 +/- 16% of baseline at 3 h). The mean cholesterol concentration in plasma was essentially unchanged. High-density lipoprotein cholesterol (HDL-C) was significantly decreased (94 +/- 2% at 3 h, P less than 0.001). VLDL-C and low-density lipoprotein cholesterol (LDL-C), estimated by the Friedewald formula, were compared with measurements obtained by modified Lipid Research Clinics (LRC) methodology. As measured by either method, VLDL-C increased and LDL-C decreased significantly after the fat-rich meal. These postprandial changes were significantly greater (P less than 0.01) when estimated by the Friedewald formula than by LRC methodology. We conclude that (a) lipoprotein cholesterol concentrations measured in the fed subject differ significantly from those measured in the fasted subject, and (b) plasma must be obtained after at least a 12-h fast if an individual's risk of coronary heart disease is to be accurately assessed.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
A. Kelley-Hedgepeth, D. M. Lloyd-Jones, A. Colvin, K. A. Matthews, J. Johnston, M. R. Sowers, B. Sternfeld, R. C. Pasternak, C. U. Chae, and for the SWAN Investigators
Ethnic Differences in C-Reactive Protein Concentrations
Clin. Chem., June 1, 2008; 54(6): 1027 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. S Lund, L. Tarnow, M. Frandsen, U. M Smidt, O. Pedersen, H.-H. Parving, and A. A Vaag
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Eur. J. Endocrinol., January 1, 2008; 158(1): 35 - 46.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
Y. Soyama, K. Miura, Y. Morikawa, M. Nishijo, Y. Nakanishi, Y. Naruse, S. Kagamimori, and H. Nakagawa
High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study
Stroke, April 1, 2003; 34(4): 863 - 868.
[Abstract] [Full Text] [PDF]

Home page
 PsychosomaticsHome page
S. B. Sonawalla, G. I. Papakostas, T. J. Petersen, A. S. Yeung, M. M. Smith, A. H. Sickinger, J. Gordon, J. A. Israel, J. R. Tedlow, S. Lamon-Fava, et al.
Elevated Cholesterol Levels Associated With Nonresponse to Fluoxetine Treatment in Major Depressive Disorder
Psychosomatics, August 1, 2002; 43(4): 310 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K.-Z. Liu, R. A. Shaw, A. Man, T. C. Dembinski, and H. H. Mantsch
Reagent-free, Simultaneous Determination of Serum Cholesterol in HDL and LDL by Infrared Spectroscopy
Clin. Chem., March 1, 2002; 48(3): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Nauck, G. R. Warnick, and N. Rifai
Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation
Clin. Chem., February 1, 2002; 48(2): 236 - 254.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
M. GARLAND, D. HICKEY, A. CORVIN, J. GOLDEN, P. FITZPATRICK, S. CUNNINGHAM, and N. WALSH
Total serum cholesterol in relation to psychological correlates in parasuicide
The British Journal of Psychiatry, July 1, 2000; 177(1): 77 - 83.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
B. S. Ticho, E. J. Neufeld, J. W. Newburger, N. Harris, A. Baker, and N. Rifai
Utility of Direct Measurement of Low-Density Lipoprotein Cholesterol in Dyslipidemic Pediatric Patients
Arch Pediatr Adolesc Med, August 1, 1998; 152(8): 787 - 791.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. Rifai, E. Iannotti, K. DeAngelis, and T. Law
Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method
Clin. Chem., June 1, 1998; 44(6): 1242 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. Harris, V. Galpchian, J. Thomas, E. Iannotti, T. Law, and N. Rifai
Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate–Mg2+ method
Clin. Chem., May 1, 1997; 43(5): 816 - 823.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.